Jost LM - Search Results

1

[High-dosage chemo-radiotherapy with autologous bone marrow transfusion in malignant lymphoma: indications and personal experience].

Stahel RA, Jost LM, Burger J, Honegger HP, Brun del Re GP, Gmür J. Stahel RA, et al. Among authors: jost lm. Schweiz Med Wochenschr. 1989 Jun 24;119(25):911-7. Schweiz Med Wochenschr. 1989. PMID: 2667131 German.

2

[Immunotherapy of tumors using interleukin-2 and lymphokine-activated killer cells].

Jost LM, Gmür J, Oelz O, Sauter C, Stahel RA. Jost LM, et al. Schweiz Med Wochenschr. 1988 Feb 4;119(5):137-43. Schweiz Med Wochenschr. 1988. PMID: 3266369 German.

3

Randomized study of recombinant human granulocyte colony-stimulating factor after high-dose chemotherapy and autologous bone marrow transplantation for high-risk lymphoid malignancies.

Stahel RA, Jost LM, Cerny T, Pichert G, Honegger H, Tobler A, Jacky E, Fey M, Platzer E. Stahel RA, et al. Among authors: jost lm. J Clin Oncol. 1994 Sep;12(9):1931-8. doi: 10.1200/JCO.1994.12.9.1931. J Clin Oncol. 1994. PMID: 7521907 Clinical Trial.

4

Short-term weekly chemotherapy followed by high-dose therapy with autologous bone marrow transplantation for lymphoblastic and Burkitt's lymphomas in adult patients.

Jost LM, Jacky E, Dommann-Scherrer C, Honegger HP, Maurer R, Sauter C, Stahel RA. Jost LM, et al. Ann Oncol. 1995 May;6(5):445-51. doi: 10.1093/oxfordjournals.annonc.a059214. Ann Oncol. 1995. PMID: 7545428 Free article. Clinical Trial.

5

High-dose chemotherapy and autologous bone marrow transplantation for malignant lymphomas.

Stahel RA, Jost LM, Pichert G, Widmer L. Stahel RA, et al. Among authors: jost lm. Cancer Treat Rev. 1995 Jan;21(1):3-32. doi: 10.1016/0305-7372(95)90009-8. Cancer Treat Rev. 1995. PMID: 7859225 Review. No abstract available.

6

[5 years of dosage intensification and autologous bone marrow or peripheral stem cell transfusion in malignant lymphoma with a high risk of recurrence].

Jost LM, Pichert G, Reichlin M, Müller E, Jacky E, Honegger HP, Gmür J, Stahel RA. Jost LM, et al. Schweiz Med Wochenschr. 1993 May 8;123(18):932-40. Schweiz Med Wochenschr. 1993. PMID: 8098878 German.

7

[High-dose chemotherapy with autologous bone marrow transplantation: 11 years' experience in Zurich].

Jost LM, Honegger HP, Stahel RA. Jost LM, et al. Schweiz Med Wochenschr. 2000 Jan 22;130(3):60-9. Schweiz Med Wochenschr. 2000. PMID: 10683881 German.

8

Placebo controlled phase I/II study of subcutaneous GM-CSF in patients with germ cell tumors undergoing chemotherapy.

Jost LM, Pichert G, Stahel RA. Jost LM, et al. Ann Oncol. 1990 Nov;1(6):439-42. doi: 10.1093/oxfordjournals.annonc.a057799. Ann Oncol. 1990. PMID: 1707298 Free article. Clinical Trial.

9

Tolerance and effectiveness of recombinant interleukin-2 (r-met Hu IL-2 [ala-125]) and lymphokine-activated killer cells in patients with metastatic solid tumors.

Stahel RA, Sculier JP, Jost LM, Delforge A, Bron D, Gmür J, Oelz O, Sauter C, Stryckmans P, Klastersky J. Stahel RA, et al. Among authors: jost lm. Eur J Cancer Clin Oncol. 1989 Jun;25(6):965-72. doi: 10.1016/0277-5379(89)90155-7. Eur J Cancer Clin Oncol. 1989. PMID: 2787749

10

Randomized trial showing equivalent efficacy of filgrastim 5 micrograms/kg/d and 10 micrograms/kg/d following high-dose chemotherapy and autologous bone marrow transplantation in high-risk lymphomas.

Stahel RA, Jost LM, Honegger H, Betts E, Goebel ME, Nagler A. Stahel RA, et al. Among authors: jost lm. J Clin Oncol. 1997 May;15(5):1730-5. doi: 10.1200/JCO.1997.15.5.1730. J Clin Oncol. 1997. PMID: 9164179 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters